Abbott India

Abbott India

ABBOTINDIA

 ₹ 30,123.88
- ₹ 238.06
0.78%
Healthcare
 ₹ 0.00
(%)1D
Updated: 27 Mar 2025, 09:31:20 am IST
Stock Score
Open Price
 ₹ 30,028.82
Prev. Close
 ₹ 30,361.94
 ₹ 29,914.16
Day Low
 ₹ 30,318.73
Day High

 ₹ 24,976.17
52 Week Low
 ₹ 31,587.21
52 Week High

Quick Bite

Price To Earnings Ratio

53.29

Sector PE

63.35

PB Ratio

17.50

Sector PB

8.19

EPS

565.28

Dividend Yield

1.52

Today's Volume

7.691 K

5 Day Avg. Volume

7.611 K

PEG Ratio

2.01

Market Cap.

₹ 64,370.00 Cr.

News & Events

About Abbott India

Abbott India Limited is an India-based company engaged in the pharmaceuticals business. The Company is involved in product development, manufacturing, and sales of healthcare products. It operates in a single reportable business segment, which is Pharmaceuticals. It distributes products and solutions in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, Central Nervous System, Vaccines, Multi-Specialty, and primary care. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), and Duvadilan (preterm labor). It offers various products under brands such as Similac, PediaSure, Pedialyte, EleCare, Ensure, and Glucerna.

Abbott India Share Price

Abbott India Limited is an Indian pharmaceutical company. The company has a range of diagnostics, medical devices, nutritional products and branded generics. It offers products and solutions for various therapeutic areas such as women's and #x27 health, gastroenterology, central nervous system, metabolic, multidisciplinary, vaccines and consumer health. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (abortion and IVF), Duphalac (disease), Digene (antacid), Prothiaden (pain and depression), Influvac (flu prevention), Creon (pancreatic insufficiency), Cremalax (failure), Pankreoflat (indigestion) and Duvadilan (late labor). It offers a variety of products under brand names such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna.

Abbott India FAQs

How to Buy Abbott India Share?

up
To purchase Abbott India shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Abbott India (ticker symbol: ABBOTINDIA) on the trading platform provided by your broker and purchase the shares.

What's Abbott India share price today?

up
The stock price of Abbott India as of 02 Apr 2025 is ₹30,123.88

What is the Market Cap of Abbott India?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 02 Apr 2025, Abbott India (ticker symbol: ABBOTINDIA) has a market capitalisation of approximately ₹6,43,70,00,00,000.00

What is the PE and PB ratio of Abbott India?

up
Abbott India Ltd's price-to-book ratio as of 02 Apr 2025 is 17.5, reflecting the market's valuation compared to its asset value. As of 02 Apr 2025, the trailing twelve months P/E (price-to-earnings) ratio is 53.29, indicating the market values the company at around ₹53.29 for every ₹1 of earnings

What is the 52 Week High and Low of Abbott India Share?

up
Abbott India Ltd (ABBOTINDIA) hit its 52-week high at ₹31,587.21, and its 52-week low at ₹24,976.17.
Begin your investment journey today
Login/Register
Start Now